PERCEPTIVE ADVISORS LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-19 9:44 pm Sale | 2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,770,792 4.100% | -1,684,184 (-48.75%) | Filing |
| 2024-11-14 4:30 pm Purchase | 2024-08-07 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 3,454,976 8.800% | 380,434 (+12.37%) | Filing |
| 2023-10-23 4:20 pm Unchanged | 2023-10-20 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 10.100% | 0 (Unchanged) | Filing |
| 2023-09-28 9:51 pm Purchase | 2023-09-26 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 23.700% | 866,789 (+39.26%) | Filing |
| 2023-08-15 4:15 pm Unchanged | 2023-08-15 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 2,207,753 22.100% | 0 (Unchanged) | Filing |
| 2023-06-06 4:17 pm Purchase | 2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 2,207,753 27.000% | 178,298 (+8.79%) | Filing |
| 2023-05-30 4:15 pm Purchase | 2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 2,029,455 24.800% | 85,000 (+4.37%) | Filing |
| 2023-05-25 4:58 pm Purchase | 2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,944,455 23.800% | 80,000 (+4.29%) | Filing |
| 2023-05-18 4:32 pm Purchase | 2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,864,455 22.800% | 1,864,455 (New Position) | Filing |